US Broker Ratings

Gilead Sciences, Inc. (GILD) Stock Analysis: A Healthcare Giant with a 15% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Foster City, California, Gilead has built a robust..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 50% Potential Upside for Investors

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $95.46 billion, the company..

Novartis AG (NVS) Stock Analysis: Navigating Growth with a Strong 3.12% Dividend Yield

As one of the leading global healthcare companies, Novartis AG (NYSE: NVS) stands out in the competitive landscape of drug manufacturing. Headquartered in Basel, Switzerland, Novartis is a formidable player..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering a 16% Upside Potential Amidst Robust Dividend Yields

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture investor attention with its compelling mix of strong financial metrics and strategic positioning in the pharmaceutical..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

UnitedHealth Group (UNH) Stock Analysis: Navigating a 11% Potential Upside in Healthcare

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare sector, commanding a significant market presence with a capitalization of $294.66 billion. As a key entity within..

AbbVie Inc. (ABBV) Stock Analysis: An In-Depth Look at Its 19.49% Upside Potential

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, has been a stellar performer in the drug manufacturing industry. With a market capitalization of $368.57 billion, the company continues..

Abivax SA (ABVX) Stock Analysis: Understanding the 26.72% Potential Upside in Biotech Innovation

Abivax SA (ABVX) is making waves in the biotechnology sector as a promising player headquartered in Paris, France. With a market cap of $9.97 billion, this clinical-stage biotechnology company is..

Kamada Ltd. (KMDA) Stock Analysis: Assessing a 57.77% Upside Potential in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israel-based leader in the specialty and generic drug manufacturing segment, is capturing investors’ attention with its promising upside potential. Currently trading at $8.24, the company’s..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Sector with a Potential 9% Upside

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) stands at an intriguing crossroads within the biotechnology sector. With a market capitalization of $492.3 million, this Boston-based company is carving a niche in..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 93% Potential Upside Amidst Analyst Enthusiasm

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a burgeoning force in the biotechnology sector, is capturing investor attention with a staggering potential upside of 93%, as projected by a consensus of market..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring a 61% Upside Potential in the Rare Disease Market

Eton Pharmaceuticals, Inc. (ETON), a specialized player in the healthcare sector focusing on treatments for rare diseases, is capturing the attention of investors with its substantial growth trajectory and potential..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 39% Potential Upside

Investors with an eye on the healthcare sector may want to take a closer look at Emergent BioSolutions Inc. (NYSE: EBS), a company renowned for its focus on providing solutions..

COMPASS Pathways Plc (CMPS) Stock Analysis: Unveiling a 226% Potential Upside in Psychedelic Therapies

For investors seeking opportunities in the healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS) presents a compelling case with its substantial potential upside. As a pioneer in the burgeoning field of..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Growth in the Medical Care Facilities Sector

Enhabit, Inc. (NASDAQ: EHAB) stands as a noteworthy player in the healthcare sector, specializing in home health and hospice services across the United States. With a market capitalization of $703.33..

Cogent Biosciences, Inc. (COGT) Investor Outlook: 49.67% Potential Upside in Precision Therapy Innovation

Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention with its innovative approach to precision therapies targeting genetically defined diseases. As a clinical-stage biotechnology company, Cogent is pushing the boundaries..

Talkspace, Inc. (TALK) Stock Analysis: Exploring an 18.96% Upside in the Virtual Healthcare Arena

Investors seeking exposure to the burgeoning virtual healthcare landscape should take a closer look at Talkspace, Inc. (NASDAQ: TALK). Specializing in behavioral healthcare, Talkspace connects patients with licensed mental health..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a 25% Potential Upside in the Biotech Sector

Fortrea Holdings Inc. (FTRE), a promising player in the healthcare sector with a focus on biotechnology, is capturing the attention of investors with a notable potential upside of 25.51%. As..

Myriad Genetics, Inc. (MYGN) Investor Outlook: Exploring Potential Upside Amidst Challenging Metrics

Investors eyeing Myriad Genetics, Inc. (NASDAQ: MYGN) are met with a complex tapestry of opportunities and challenges as they navigate the stock’s current landscape. With a market capitalization of $472.22..

Prothena Corporation (PRTA) Stock Analysis: Unveiling a Potential 99% Upside in Biotech Innovation

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company headquartered in Dublin, Ireland, stands out in the healthcare sector with its cutting-edge focus on treating diseases caused by protein dysregulation. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds